ORIC-114 Dose 1 + amivantamab
ORIC-114-05
Phase 1 small_molecule active
Quick answer
ORIC-114 Dose 1 + amivantamab for Solid Tumors is a Phase 1 program (small_molecule) at Oric Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oric Pharmaceuticals
- Indication
- Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active